Role of serum C-reactive protein as a marker of hepatocellular carcinoma in patients with cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 4, 2000, Pages 417-421

  Lin, Zu Yau ^a   Wang, Liang Yen ^a   Yu, Ming Lung ^a   Chen, Shinn Cherng ^a   Chuang, Wan Long ^a   Hsieh, Ming Yuh ^a   Tsai, Jung Fa ^a   Chang, Wen Yu ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

C reactive protein; Hepatocellular carcinoma; Liver cirrhosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0034114447     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02149.x     Document Type: Article

References (19)

1. Munoz N, Bosch X. Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987; 3-19.
2. Kobayashi K, Sugimoto T, Makino H et al. Screening methods for early detection of hepatocellular carcinoma. Hepatology 1985; 5: 1100-5.
3. Liaw YF, Tai DI, Chu CM et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. Gastroenterology 1986; 90: 263-7.
4. Sawabu N, Hattori N. Serological tumor markers in hepatocellular carcinoma. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987; 227-37.
5. Okuda K. Clinical aspect of hepatocellular carcinoma: Analysis of 134 cases. In: Okuda K, Peters RL, eds. Hepatocellular Carcinoma. New York: Wiley, 1976; 387-405.
6. Chen DS, Sung JL, Sheu JC et al. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 1984; 86: 1404-9.
7. Sheu JC, Sung JL, Chen DS et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985; 89: 259-66.
8. Lee FY, Lee SD, Tsai YT, Wu JC, Lai KH, Lo KJ. Serum C-reactive protein as a serum marker for the diagnosis of hepatocellular carcinoma. Cancer 1989; 63: 1567-71.
9. Fabris C, Pirisi M, Soardo G et al. Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis. J. Cancer Res. Clin. Oncol. 1994; 120: 229-32.
10. Fabris C, Pirisi M, Soardo G et al. Diagnostic usefulness of acute-phase protein measurement in hepatocellular carcinoma. Cancer Invest. 1996; 14: 103-8.
11. Thung SN, Gerber MA. Cirrhosis and hepatocellular carcinoma. In: Okuda K, Tabor E, eds. Liver Cancer. Tokyo: Churchill Livingstone, 1997; 155-63.
12. Tilg H, Wilmer A, Vogel W et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-74.
13. Moine OL, Devère J, Devaster JM et al. Interleukin-6: An early marker of bacterial infection in decompensated cirrhosis. J. Hepatol. 1994; 20: 819-24.
14. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factor for liver cirrhosis and cirrhotic hepatocellular carcinoma: A case-control study. Liver 1994; 14: 98-102.
15. Ohto M, Ebara M, Okuda K. Ultrasonography in the diagnosis of hepatic tumor. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987; 251-8.
16. Friedman AC, Johns T, Levy DW, Rindsberg S, Markle BM. Cirrhosis, other diffuse diseases, portal hypertension, and vascular diseases. In: Friedman AC, ed. Radiology of the Liver, Biliary Tract, Pancreas and Spleen. Baltimore: Williams & Wilkins, 1987; 69-88.
17. Goldman ND, Liu TY. Biosynthesis of human C-reactive protein in cultured hepatoma cells is induced by a monocyte factor(s) other than interleukin-1. J. Biol. Chem. 1987; 262: 2363-8.
18. Gabay C, Genin B, Mentha G, Iynedjian PB, Roux-Lombard P, Guerne PA. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells. Clin. Exp. Immunol. 1995; 100: 306-13.
19. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 1994; 15: 81-8.